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Nova Scotian Bees as sources of antimicrobial compounds against American 
Foulbrood Disease 
 
by Prashansa Kooshna 
 
Abstract  
Honey bees, Apis mellifera, face many parasites and pathogens such as 
Paenibacillus larvae, the causal agent of American Foulbrood disease (AFB), a highly 
contagious disease. Honey bees rely on a diverse set of individual and group-level 
defenses to prevent disease. One route by which honey bees might combat disease is 
through the protective effects of their microbial symbionts. This study focuses on 
microbial interactions in bees that help in fighting AFB through the inhibition of P. 
larvae. 
Honey bees and wild bees in Nova Scotia were sampled for microbial isolation 
and screened against P. larvae using pairwise antimicrobial assay. Isolates showing good 
inhibition were chosen for extraction of metabolites with ethyl acetate and 1:1 
chloromethane-methanol to obtain antimicrobial compounds that inhibit P. larvae. The 
extracts were analysed using LC/DAD and UHPLC/MS. 
Novel microbial species such as Pseudomonas chloroaphis, Debaromyces 
prosopidis and Paenibacillus lactis along with previously reported B. cereus and B. 
subitilis, were isolated from beehive swabs and showed strong inhibition against P. 
larvae. Chloroform: Methanol extracts of E8 that is a mixture of at least 6 microbial 
strains and of A12 showed strong inhibition while ethyl acetate extracts showed moderate 
inhibition against P. larvae. Our findings show great potential for discovery of novel 
antagonistic compounds against AFB. 
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1.0. Importance of honey bees  
 Honey bees (Apis mellifera) contribute to the ecosystem and economy through 
their pollination services, benefiting humans both directly and indirectly. It was reported 
by Mendleson that honey bee pollination is worth about $1.7 billion in Canada.1 Around 
380 000 beehives in Canada, which is half the stock of Canadian beehives, are 
responsible for the pollination of canola seeds only. Moreover, fifty-two of the 115 
leading global commodities depend on honey bee pollination. For instance, 80% of the 
world’s supply of almonds are pollinated by millions of beehives. Some honey bee-
dependent commodities can face a decline of more than 90% in their yield without honey 
bees.1  
1.0.1 The status quo honey bee population 
While global honey bee populations have been increasing, the rate of increase is 
not keeping pace with demand. The proportion of land dedicated to the production of 
pollinator-independent crops has shrunk when compared to land used for cultivation of 
pollinator-dependent crops. Furthermore, in spite of the global increase in honey bee 
populations, some parts of Europe and North America have been facing declines in honey 
bee populations.2,3  
Managed honey bee populations are influenced by many factors including 
diseases, parasites, pesticides, the environment, and socio-economic factors.  American 
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foulbrood disease (AFB) is the most serious bacterial disease of the honey bee.4 Of all 
diseases affecting honey bees, AFB has had the greatest impact on the industry. In 2000, 
annual economic loss attributed to AFB infection in US was around USD $5 million.5 
 1.1 American Foulbrood disease 
American Foulbrood disease is a worldwide problem; it has been reported that 
Paenibacillus larvae spores, the causal agent of the disease, were found in honey samples 
in regions of US, sub Saharan Africa and South America.5,6,7 Prevention and control of 
the disease are challenging because P. larvae form spores that can survive environmental 
adversities for long periods of time.8 AFB affects honey bees at a larval stage and can 
wipe out a whole generation, through larval death within only 6 to 12 days.8 Antibiotics 
tylosin and oxytetracycline were approved by the FDA to be used against P. larvae.9,10,11 
However, the pathogen developed drug resistance against both antibiotics. Moreover, 
higher doses of those antibiotics are harmful for human consumption of the honey. Thus, 
beekeepers resort to burning infected hives to contain the disease. 
1.1.1 Pathogen, Paenibacillus larvae 
Paenibacillus larvae, which is part of the genus Paenibacillus, is a rod-shaped, 
facultative anaerobic, spore forming and gram-positive bacteria.8,12 P. larvae has been 
classified into four different genotypes (Enterobacterial Repetitive Intergenic Consensus 
ERIC I–IV).13 These genotypes differ phenotypically with respect to spore and colony 
morphology, metabolism, and most importantly virulence.14,15,16  The genotypes ERIC I 
and ERIC II are regularly isolated from infected colonies worldwide, whereas ERIC III 
and ERIC IV are only represented by few historical isolates in type culture collections.17 
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Based on genomic data, it has been proposed that P. larvae ERIC I and II evolved 
different strategies to achieve invasion of the hemocoel. The hemocoel is the body cavity 
in bees, comprising a series of interconnected spaces between tissues and organs, through 
which a mixture of blood and lymphatic fluid (hemolymph) flows freely.18 
It has been demonstrated that the genotype ERIC II is more virulent on the larval 
level than ERIC I. It commonly kills bee larvae within 6–7 days, while ERIC I strains 
need up to 12 days to kill all infected larvae.19 However, these differences on the 
individual larval level have different implications for virulence on the colony level, 
because the earlier larvae die, the more efficiently they can be removed by nurse bees 
engaged in brood hygiene. This is a part of the social immune response of honey 
bees.20 The social immune response is better adapted to contain ERIC II infections rather 
than ERIC I infections. This leads to the paradoxical situation that P. larvae ERIC II is 
less virulent on the colony level than ERIC I. 
Several species from Paenibacillus genus are known for their useful Paenibacillus- 
derived antimicrobial compounds such as polymyxins and fusaricidins. Moreover, many 
Paenibacillus genus species yield a range of enzymes that have several applications in 
medicine, food, textiles and biofuel.12 On the other hand, Paenibacillus larvae which is a 
pathogen releases a chitinase, that is responsible for the pathogen’s invasion of the 
midgut of honey bee larvae.4 Understanding the mechanism of the infection can provide 
better guides to solutions against AFB. 




1.2 Mechanism of pathogenicity 
1.2.1 Pathobiology of P. larvae: chitin-degrading enzymes 
In most invertebrates like bees, the role of mucus is incurred by peritrophic matrix 
(PM), the lining of the gut epithelium and provides a protective barrier against 
pathogens.22,23 The PM consist of a network of chitin containing microfibrils in a matrix 
of   proteins, glycoproteins, and proteoglycans. The major constituents are the fibrils 
made of chitin, an insoluble linear beta (1,4)-linked N-acetylglucosamine.24 
Invasive pathogens like P. larvae, need to breach the midgut epithelium before 
they can interact with the epithelial cells. Hence, degradation of the PM in the larval 
midgut is a key step in the pathogenesis of P. larvae.25 The mechanism of infection by P. 
larvae is shown in figure 1.  It was found that the chitin-degrading enzyme PlCBP49 
responsible for the degradation was not a classical chitinase as the genomic sequences of 
P. larvae did not reveal functional genes for classical chitinases. Henceforth, PlCBP49 
was classified as a novel member of auxiliary activity 10 (AA10) family of lytic 
polysaccharide monooxygenases (LPMOs).26,27,28 Members of the AA10 family are 
capable of degrading recalcitrant polysaccharides like crystalline chitin via a novel, 
copper-dependent, oxidative enzymatic mechanism.14,29,30   




Figure 1.  Pathogenesis of P. larvae infections in honey bee larvae. From stage I to II, 
honey bee larvae ingest the P. larvae spores in the contaminated food. Exposure to excess 
of nutrients in the midgut promotes spore germination (III) and allows the vegetative 
bacteria to proliferate until they occupy nearly the entire midgut lumen (IV).4 The 
invasive phase of infection is initiated by the total destruction of the midgut PM enabling 
the bacteria to cross the epithelial barrier and invade the hemocoel (V). At stage V, the 
infected larva is dead and P. larvae totally degrades the cadaver to a ropy mass and 
eventually starts forming spores again. Nurse bees trying to clean the brood cell become 
contaminated and transmit the spores to other uninfected larvae when feeding them. 
Along with the chitin degrading enzyme, certain toxins/secondary metabolites released 
by P. larvae also participate in invading of the hemocoel (Muller et al.).8  Permission for 
use of image was granted. 
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1.2.2 Pathobiology of P. larvae: toxins/secondary metabolites 
P. larvae secondary metabolites exhibiting antimicrobial activity may play a role 
during P. larvae proliferation in the midgut lumen. Only ERIC I will be discussed here as 
it is more virulent at colony level and is the one studied in this honours project.31 ERIC I-
genome harbors several functional toxin genes. Two of the ERIC I-specific toxins Plx1, 
Plx2 are novel AB-toxins. AB-toxins consist of two subunits, an enzymatically active A 
subunit and a B subunit that assist in the translocation of subunit A into the host cell. The 
A subunit inhibits normal cellular functions by modifying its target. 32  
These AB-toxins, Plx1 and Plx2 most likely act on the epithelial cells, once the 
protective PM has been degraded. Fünfhaus et al. (2013) shed light on some possibilities, 
but the actual mechanism of toxins is yet to be confirmed. They found that the Plx1 B 
subunit contained four ricin‐B‐like domains with characteristic motifs that have been 
shown to be involved in carbohydrate binding.32 Thus, Plx1 might be able to bind to 
glycoproteins or glycolipids present on honey bee larval midgut epithelial cells, 
facilitating the entry of the toxin into host cells. 33 As for Plx2, from the observed 
sequence and structural features of Plx2 A subunit, they hypothesized that activity of 
Plx2 in the host cell results in loss of the actin cytoskeleton that may lead to the observed 
rounding up of host cells in the midgut epithelium of AFB‐infected larvae.33,34 
Also, P. larvae proliferating in the larval midgut will encounter microbial 
competitors as soon as the larval food is supplemented by honey and pollen containing 
bacterial spores, bacteria, and fungi. Other secondary metabolites like paenilamicin or the 
paenilarvins will enable P. larvae to defend its niche and outcompete saprophytes during 
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degradation of the larval cadaver, thus ensuring that a pure culture of P. larvae prevails in 
the end. 35,36 
 
Figure 2. Role of toxins Plx1 and Plx2 in virulence of P. larvae. 
These toxins most likely act on epithelial cells once the 
protective PM has been degraded. P. larvae then breaches the 
epithelial layer and invades the hemocoel (Muller et al. 2014).8 
Permission for use of image was granted. 
 
1.3 Solutions 
1.3.1 Progress on fighting against AFB so far 
There is an ongoing search for antimicrobial compounds against the pathogen, P. 
larvae. Several antibiotics have been tested in vitro and in vivo against AFB such as 
oxytetracycline and tylosin. It was found that AFB was controlled by oxytetracycline 
hydrochloride, tylosin and terramycin but in all cases, colonies exhibited disease 
recurrence from five to 10 months after treatment.36 Many other potential antimicrobial 
compounds against the honey bee pathogen have recently been discovered from various 
sources such as tea tree oil, poplar resins, tilmicosin and fermented materials.38-41 For 
instance, 4 active dihydroflavonols from poplar resins (pinobanksin-3-butyrate, 
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found to inhibit P. larvae. (IC50: 17-68 µM) where an increasing antimicrobial activity 
against P. larvae was observed, with longer acyl groups.39  
Studies have also demonstrated the efficiency of probiotics in strengthening 
honey bee’s resistance against AFB. Lactic acid bacteria in genera Lactobacillus and 
Bifidobacterium, originating from honey stomach exhibited resistance both in vitro and in 
vivo against P. larvae and was proposed as candidates for use as probiotics against 
AFB.42 Lactobacillus plantarum  (ATCC 14917), Lactobacillus rhamnosus (ATCC 
55826), and Lactobacillus kunkeei (previously isolated from a healthy honey bee hive) 
were tested as probiotics to provide resistance against AFB among honey bees and found 
to reduce pathogen load, upregulate expression of key immune genes, and improve 
survival during P. larvae infection.43 These findings show that the use of probiotics 
supplement can be a practical and affordable solution for beekeepers. The use of 
probiotics can be a cheaper alternative compared to antibiotics as the cost of synthesis of 
antibiotics is likely to be higher. 
1.3.2 Microbiome of honey bee as source of active compounds 
A study found that seven strains showed strong inhibitory activity against P. 
larvae out of 35 isolates from the digestive tract of the Japanese honey bee, Apis cerana 
japonica. Most of the antagonistic bacteria belonged to Bacillus species and the strong 
inhibitory strains were closely related to the subtilis and cereus subspecies.44 Another 
study by Alippi and Reynaldi45 tested 242 isolates from apiarian sources in Argentina 
from which 49% produced no inhibition, 28% produced medium inhibition, 12% 
produced good inhibition, and 11% produced very good inhibition. Within those 11% 
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(26) strains that showed very good inhibition, 10 strains were selected and identified as: 
Bacillus subtilis, Bacillus pumilus, Bacillus licheniformis, Bacillus cereus, Bacillus 
megaterium, Brevibacillus laterosporus, Bacillus laterosporus.  
Furthermore, a bacterial strain showing a high level of antimicrobial activity 
against P. larvae ATCC 9545 was isolated from honey samples and identified as 
Paenibacillus polymyxa. 46 
1.3.3 Microbiome of wild bees as source of active compounds 
It was found by Keller and co-workers that Paenibacillus strains with genes 
encoding the virulence factors or chitinases of American Foulbrood disease were not 
found among 13 species of wild bees.47 Hence, it is possible that wild bees have co-
evolved with some immune responses against AFB. For instance, Olofsson and 
Vasquez42 (2008) reported a novel bacterial flora composed of lactic acid bacteria of the 
genera Lactobacillus and Bifidobacterium, in Apis mellifera honey stomach. 
However, Evans and Armstrong48 (2006) failed to find Lactobacillus species in A. 
mellifera, suggesting that the gut microbial population is not constant even within the 
same species. Therefore, it can be hypothesized that wild bees have different gut 
microbiomes too. Their gut microbiomes can also be potent sources of antimicrobial 
compounds if wild bees have evolved with a microbiome against diseases such as AFB. 
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1.4 Theory behind methods  
1.4.1 Finding potential inhibitors  
There are countless microorganisms thriving in the bee microbiome that may 
be producing potent antimicrobial compounds. The isolation of microbes depends on 
several factors such as nutrient availability, nature of substrate, oxygen levels and 
temperature. Also, the presence and nature of competitors (other surrounding microbes) 
can affect the chemical composition of the media as they produce secondary 
metabolites that can inhibit or promote growth of other strains. Many of those factors, 
such as presence of competitors, cannot be controlled at the beginning stage. Therefore, 
the choice of media and physical conditions are crucial in maximizing the number of 
isolates.  
General media allow the growth of non-fastidious microorganisms while 
selective media will support fastidious organisms, which need a specific set of 
requirements met, to grow. Nutrient agar (NA) was used as general media, while 
nutrient agar with antibiotic ampicillin (NAA) was used to favor fungal growth and 
nutrient agar with fungicide cycloheximide (NAC) was used for selective growth of 
bacteria. 
Streaking colonies aseptically leads to the isolation of individual colonies, 
which are a group of microbial cells that came from one single progenitor microbe.54 
An antimicrobial assay that can screen several strains at once, is needed to find potential 
producers of antimicrobial compounds. Twelve well plates pairwise assay allow us to 
conduct several pairwise tests at once. 
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1.4.2 Identification of inhibitors  
DNA extraction and primers used 
For DNA (deoxyribonucleic acid)  
extraction, cells and their nuclei need to be broken open. This can be 
accomplished by mechanical methods, such as grinding, or by chemical methods that 
break apart cell walls and cell membranes. The use of ethanol helps in precipitating DNA 
and removing salts by solvating them better than DNA. 
For bacterial identification, 16S ribosomal RNA (16S rRNA) is targeted and 
sequenced as it is a highly conserved region of the bacterial genome. 16S rRNA is the 
component of the 30S small subunit of a prokaryotic ribosome that binds to the Shine-
Dalgarno sequence. The Shine-Dalgarno sequence is a ribosomal binding site in bacterial 
and archaeal messenger RNA, (mRNA) that helps to recruit mRNA for protein 
synthesis.49,50,51  
Fungi also have an internal transcribed spacer (ITS), which is a highly conserved 
cluster present in the rRNA. This cluster encodes three subunits of ribosomal RNA; 18S 
(small subunit), 5.8S and 28S (large subunit) and ITS region. An important attribute of 
the ITS sequences for molecular phylogenetic research is that they show significant 
variations between closely related fungi, and sometimes between populations within a 
single species. These variations are caused by insertions, deletions, and point mutations, 
which are conserved in the ITS region.52,53 
 
 




This sequencing procedure which is dideoxy sequencing was invented by Frederic 
Sanger and his colleagues in 1977. With a few modifications and automation, this method 
is still used today in genomics, allowing large sequencing centers to read over 1,000 
bases of DNA sequence per second.55  
Sanger sequencing test samples consist of the extracted DNA of test organism, 
primers that are oligonucleotides of around 20 base pairs long and complementary to the 
target DNA The sample mixture is added to four tubes containing one of the four dNTPs 
(deoxyribonucleotides), their corresponding ddNTPs (dideoxyribonucleotide) and DNA 
polymerase. 
Each tube first undergoes heating to separate the double stranded DNA by 
disrupting the hydrogen bonds and van der Waals forces of attraction. The DNA primer is 
then annealed at one end of the sequence of interest on the DNA strands, which act as 
template strands for DNA polymerase.  
DNA polymerase extends the oligonucleotide, using the template strand to guide 
incorporation of dNTPs. Randomly, a ddNTP will be incorporated into the growing DNA 
strand. Because it is missing the 3’ hydroxyl group, the ddNTP will prevent the DNA 
chain from being extended further.  
In addition, each ddNTP has a different color label. Consequently, each 
terminated DNA chain is colored according to the nucleotide at its end. When the DNA 
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strands are separated by length by capillary electrophoresis, individual chains of 
increasing length can be identified by their color.55 
 
Figure 3. Scheme showing how the ddNTPs causes termination in Sanger sequencing by 
stopping DNA polymerase from elongating DNA strand and can be used to sequence 
DNA.54 Permission for use of image was granted. 
 
The resulting fragments 
are separated in a single 
lane of gel, where they 
move down quicker or 
slower according to size 
Various samples of DNA 
are subjected to the 
dideoxy reaction, but a 
different colour dye 
(shown by arrows) is 
attached to each primer 
A laser source at the 
bottom of the lane 
detects the colours and 
sends the corresponding 
information to a 
computer, which deduces 
the sequence. 
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Analysis of sequence 
A sequence similarity search allows scientists to deduce the function of a 
sequence from similar sequences. The sequence received from Sanger sequencing can be 
analysed with various bioinformatic tools. BLAST (Basic Local Alignment Search Tool) 
is a well-known program that finds regions of local similarity between sequences. The 
program compares nucleotide or protein sequences to sequence databases and calculates 
the statistical significance of matches.  This can be used to help identify members of gene 
families or infer functional and evolutionary relationships between sequences. 
The BLASTN nucleotide-nucleotide search looks for more distant sequences while 
the megaBLAST nucleotide-nucleotide search is optimized for very similar sequences in 
the same or in closely related species. MegaBLAST first looks for an exact match of 28 
bases, and then attempts to extend that initial match into a full alignment.55  
1.4.3 Target secondary metabolites and extraction  
Antimicrobial activity is caused by the production of an array of secondary 
metabolites of bacteria and fungi such as peptides, lipopedtides, β-lactams, glycopeptides, 
lantibiotics, surfactins and many more.56,57,58 The method of extraction varies according 
to the nature of target compounds. A common point observed from previous studies is the 
use of methanol or precipitation by ammonium sulphate or concentrated acid to extract 
antimicrobial compounds. Acetone and chloroform were also used to extract 
antimicrobial compounds from microbes.59,60,61 
Bacillus subtilis, isolated from honey and bee gut samples showed very good 
inhibition in Alippi and Reynaldi’s study45 (2006), and is known for producing surfactin. 
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Natural surfactin produced by B. subtilis is a mixture of isoforms with slightly different 
properties as a result of substitutions in amino acids and the aliphatic chain. Cell free 
supernatants of the B. subtilis cultures were precipitated with concentrated HCl and was 
then extracted with methanol. Vegetative cells of P. larvae were affected as soon as they 
came in contact with the surfactin sample in their antimicrobial assay.45  
Bacillus cereus, another strain that has been showing very good inhibition in 
previous studies, has been fairly well investigated for its useful or toxic secondary 
metabolites. Bizanni and Brandelli (2002) identified a bacteriocin produced by the 
bacterium Bacillus cereus 8 A that could be used in food safety. Conversely, it was also 
found that Bacillus cereus produces food poisoning toxins such as an emetic that causes 
vomiting.  The emetic toxin has been named cereulide and consists of a ring structure of 
three repeats of four amino and/or oxy acids: [D-O-Leu-D-Ala-L-O-Val-L-Val]3. This 
dodecadepsipeptide has a molecular mass of 1.2 kDa and is chemically closely related to 
the potassium ionophore valinomycin, which is a potent antibiotic that translocates K+ 
ions across cell membranes.62,63 
Another study isolated bacteriocin-like inhibitory substances (BLIS) that are 
antagonistic to P. larvae from B. cereus isolated from apiarian sources. Both BLIS have a 
narrow activity range and highly inhibit the growth of P. larvae. An electrophoretic 
analysis of the proteins in a BLIS molecule, showed three bands having apparent 
molecular weights of about 6.2, 14.4 and 17.1 kDa respectively.61 
 Paenibacillus polymyxa isolated from honey samples, produced an antimicrobial 
compound of molecular mass 1168.78 Da, matching that of polymyxin E1.The 
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antimicrobial compound was purified by 80% saturated ammonium sulfate precipitation 
followed by carboxymethyl-sepharose chromatography and characterised by reverse-
phase HPLC and electrospray ionization -quadrupole time of flight mass spectrometry 
(ESI-qTOF MS).46 
1.4.4 Purification & analysis of active compounds  
High Performance Liquid Chromatography Mass Spectrometry (HPLC/MS) 
The target molecules of this project are small antimicrobial compounds with 
molecular weights below 2 kDa. Reversed phase HPLC (RP-HPLC) successfully 
separates both polar and nonpolar neutral molecules with molecular weights below 2000 
Daltons.   
RP- HPLC is characterized by a situation in which the mobile phase used is more 
polar than the stationary phase. For neutral analytes, the mobile phase consists of water 
(the more polar component) and an organic modifier, which is commonly known as the 
organic phase. The organic modifier lowers the polarity of the mobile phase leading to a 
variation in the retention of analytes. In reverse phase column chromatography, stationary 
phase is usually comprised of C-18 column. Water is usually used as the aqueous mobile 
phase and methanol or acetonitrile as organic modifiers. When ionic analytes are present, 
other additives such as buffers or ion pairing reagents can be added to the mobile phase to 
control retention and reproducibility. Formic acid is commonly used as an additive. 
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Chromatographically, in RP-HPLC water is the ‘weakest’ solvent as, being the 
most polar, it repels the hydrophobic analytes into the stationary phase more than any 
other solvent, hence lengthening retention times. 
When the organic modifier is added, the hydrophobic part of the analyte is no 
longer as strongly repelled into the stationary phase, spends less time in the stationary 
phase, and therefore elutes earlier.  
Alternative methods if RP-HPLC cannot separate compound depends on the nature 
of the compound. normal phase or hydrophilic interaction liquid chromatography (HILIC) 
can be used for very hydrophilic compounds which may have too short retentions in RP.  
On the other hand, non-aqueous reversed phase chromatography (NARP) can be 
used if analyte is very hydrophobic which is indicated by strong retention under reversed 
phase conditions and may require the use of non-aqueous conditions.  
LC/DAD 
UV-Vis chromatography uses light over the ultraviolet range (185 - 400 nm) and visible 
range (400 - 700 nm) of electromagnetic radiation spectrum. From literature, it was found 
that isolated antimicrobial compounds tend to be in the ultraviolet range which is why 
samples are analysed  at wavelengths of 212, 225, 254, 275 and 350 nm to detect peptide 
compounds in the range of 200 to 225 nm and aromatic compounds higher than 225 nm.64 
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1.4.5 Testing extracts 
Several well- known bioassays such as disk-diffusion, well diffusion and broth 
or agar dilution are commonly used, but others such as flow cytofluorometric and 
bioluminescent methods are not widely used as they require specialised equipment. This 
makes the latter methods less appealing for preliminary tests of activity from unknown 
compounds even if they can provide rapid results of the antimicrobial agent's effects.   
The agar well diffusion method is commonly used to evaluate the antimicrobial 
activity of microbial extracts. The agar plate surface is inoculated by spreading a volume 
of the microbial inoculum to be tested against over the entire agar surface. Then, a hole is 
punched aseptically with a 1000 µl pipette tip, and the antimicrobial agent or extract 
solution at desired concentration is introduced into the well. Agar plates are subsequently 
incubated under suitable conditions depending upon the test microorganism. The 
antimicrobial agent diffuses in the agar medium and inhibits the growth of the microbial 
strain tested. The radius of inhibition can then be used to quantitatively compare the 
activity of the extracts. 65 
1.5 Objectives 
The objective of this study is to find and characterise antimicrobial compounds 
against AFB that are harmless to both humans and bees using the microbiome of bees. 
Since testing the found antimicrobial compounds on human and animals is out of this 
study’s scope, the antimicrobial compounds showing high inhibition at low 
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concentrations will be ideal, in the hopes that they will also be less toxic. We are also 
open to finding isolates that has the potential to be used as probiotics against AFB.  
Moreover, we are interested in investigating if wild bees have some strong 
inhibitory microbes against AFB, as it was reported in a study (Keller et al.)47 that the 
pathogen P. larvae was not found among any of the wild bees sampled.  
For honey bees, the exteriors, beehive swabs and guts will be isolated, while for 
the wild bees, the guts and exteriors only will be isolated. Bombus species (bumble bees) 
and Andrena species (mining bees) will be used as a model for wild bees due to the ease 
of their collection. The strains isolated from the samples will be tested against P. larvae 
in a pairwise assay in 12 well plates. Strains showing inhibition will then be inoculated in 
larger scale to extract secondary metabolites using ethyl acetate (EA), methanol and 
chloroform as solvents. The extracts will be fractionated and tested against P. larvae. The 
active fractions will then be characterized using LC-MS, IR and NMR spectroscopies.  
The activity of the extracts will be tested against P. larvae using well diffusion 
assay. An average of the radius of inhibition will be recorded and compared with a 
negative control such as sterile water and extracts of nutrient agar. 
2. Experimental  
2.1 Sample Collection and processing of bee samples 
Along with colleagues, Morgan Crosby and Julie Anne Dayrit, honey bees and 
beehive swabs were collected from 3 different apiaries across Nova Scotia and stored in 
sterile centrifuge tubes during summer. The locations covered were Middle 
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Musquodoboit, Middle Stewiacke and Truro. The samples were processed with the help 
of Morgan Crosby. The honey bees were anesthetized by leaving the tubes in the freezer 
for half an hour to an hour before processing. The samples were processed by first 
vortexing in nutrient broth to culture the microbes on the exterior of the bees. The 
exterior ones were left to incubate for 2 weeks before re-streaking on agar plates. The 
beehive swabs were cultured in nutrient broth and left to incubate for 7 days before 
streaking on solid media. Nutrient broth (NB) was made of 5g Tryptone, 5g NaCl, 3g 
yeast extract and 1L of deionized water. Nutrient agar had the contents of nutrient broth 
along with 15 g of agar. The media were sterilized in a Getinge Vacuum Steam Sterilizer 
(Model 533Ls) at 121°C for 15 minutes.  
Bombus species (bumble bees) and Andrena species (mining bees) were collected 
as a model for wild bees in South End Halifax, with the help of Abdurrahman Elajmi. 
Those bees were chosen for collection as they could be easily found in the locality. The 
wild bees would be out in hot summer days, especially around noon and early afternoon.  
The wild bees were collected using butterfly nets and stored in sterile centrifuge 
tubes until processing. Processing and dissection of the wild bees were performed by 
Abdurrahman Elajmi and myself. Pictures of the wild bees were taken for identification 
and records.  The exteriors of the bees were cultured using the same method as the 
sample processing of honey bee exteriors. 
2.1.1 Dissection and processing of honey bee and bumblebee guts 
The Adrena bees weren’t dissected due to their narrow body size.  Dissection 
tools were sterilized by first washing with 10 % bleach solution, sterile water and then 70 
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% ethanol. The ethanol was allowed to evaporate before dissecting the bees. Firstly, the 
thorax was cut with a sterile scalpel to access the gut. The whole gut was pulled along 
with the honey stomach with sterile tweezers, as it was hard to isolate the guts without 
bursting the honey stomach. The gut samples were cultured in Peptone Yeast Extract 
Glucose (PYEG) broth (5 µg/ml Hemin, 0.5 µg/ml Vitamin K1 , 0.5 µg/ml Vitamin K2, 
20 g tryptone, 10g yeast extract, 10 g D-Glucose, 0.5g L-cysteine, 0.4g NaHCO3, 0.08g 
NaCl, 0.04g KH2PO4, 0.04g K2HPO4) for one week at 37 ˚C until growth was seen. The 
microbial cultures were then streaked on PYEG agar and incubated at 37 ˚C in 2.5 L 
anaerobic jars (Mitsubishi AnaeroPack Rectangular Jar by Thermo Scientific, R685025). 
An anaerobic indicator, Oxoid Resazurin Anaerobic indicator from Thermo Scientific 
(BR0055B) was used to monitor the anaerobic conditions of the jar. Pink colour indicates 
the presence of oxygen while white shows anaerobic conditions. 
2.2 Strain Isolation 
Colonies were isolated according to visible morphological characteristics such as 
shape (figure 4), margin or edge of colony (figure 5), colour, texture (powdery, smooth, 
fluffy) and opacity (translucent, clear, opaque).  
 
Figure 4. Types of shapes of bacterial colonies 






Figure 5. Types of edges of colonies 
2.2.1 Honey bees  
This part of the project was done with the collaboration of Morgan Crosby and 
Abdurrahman Elajmi. At the end of the incubation periods of the first cultures, the 
samples were re-streaked in 3 different media to maximize the number of strains isolated. 
Plain nutrient agar (NA), nutrient agar with 1 mg/ml cycloheximide (NAC), nutrient agar 
with 1 mg/ml ampicillin, (NAA). Ampicillin was added when the agar cools down until it 
is comfortable to touch to prevent degradation of ampicillin. 
2.2.2 Wild bees 
Twenty µl of the first cultures of the guts of the bees were re-streaked on NA 
incubated under aerobic conditions and on PYEG agar incubated in anaerobic jars at 37 
˚C. The first cultures of the exterior of the wild bees were re-streaked on NA. Only 
general media, NA, was used to reduce volume of work due to time constraints. 
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2.3 Antimicrobial screening 
A general antimicrobial screening was performed using 12 well plates to find 
potential inhibitors. The metabolites of candidates showing inhibition would then be 
extracted to further test inhibitory activity.  
2.3.1 Revival of Paenibacillus larvae 
Paenibacillus larvae (ATCC 9545) was obtained from ATCC, American Type 
culture Collection. The entire pellet was rehydrated with 500 µL of Brain Heart Infusion 
with thiamine HCl (BHIT) broth. (37 g Brain Heart Infusion extract, 1L deionized water, 
0.1 mg/L Thiamine HCl). The entire content was transferred to a 3 ml tube of BHIT broth 
(primary culture). Additional tubes of 5 ml BHIT broth were inoculated with 500 µL of the 
primary culture and left to incubate at 37°C for 48 to 72 hours under aerobic conditions. 
The primary culture was also streaked on BHIT agar and left to incubate under the same 
conditions. The P. larvae grew in the broth rather than agar after a few days. P. larvae 
liquid cultures were re-streaked on BHIT agar and on NA later, for use in antimicrobial 
assay. The appearance of the growth of the strain did not differ when media was switched 
from BHIT agar to NA. However, the P. larvae got contaminated and a new batch was 
ordered. 
Upon revival of the new batch using the aforementioned method, the P. larvae grew 
very slowly, slower than the first batch. It was also growing differently from the first batch.  
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2.3.2 General antimicrobial screening 
This part was also done in collaboration with Abdurrahman Elajmi. Antimicrobial 
screening of honey bee and wild bee gut isolates was carried out against P. larvae (ATCC 
9545) using a pairwise assay on 12 well plates as shown in figure 6. The temperature 
conditions were used according to the incubation conditions of the test isolates during 
isolation ie beehive swabs strains isolated at room temperature and 30 ˚C, exterior of bees 
at RT, gut strains which were incubated at both aerobic and anaerobic conditions at 37 
˚C. For anaerobic isolates, 12 well plates were placed in the 2.5 L AnaeroPack jar 
(Thermo Scientific) with Resazurin anaerobic indicator (Thermo Scientific).  
 
   Figure 6. Pairwise antimicrobial assay using 
12 well plates to test inhibition among bee 
isolates (test isolates) against P. larvae. The 
first column is the control which is plain 
NA, second and third column is streaked 
with test strain and P. larvae respectively 
and the last column is the pairwise test. 
 




2.3.3 Modified pairwise assay  
For pairwise assays where inhibition wasn’t clear, the test bee isolates were 
inoculated first and left to incubate for one to two weeks depending on the speed of 
growth of the test isolate. This is done to allow the test strain to produce secondary 
metabolites that may inhibit P. larvae. The P. larvae was then streaked in its control 
column and opposite to the test strain in the pairwise test column. Comparison of the 
growth of P. larvae in the pairwise test column and control was taken after 3 days and 
one week. 
 
Figure 7. Modified 12 well plates pairwise assay to test isolates from bee samples against 
P. larvae. The first column is the negative control NA, second and last column is streaked 
with test isolates first and left to incubate for one to two weeks to allow test isolates to 
produce secondary metabolites. Lastly, P. larvae is streaked in the third which acts as a 
positive control for P. larvae and last column which is the pairwise test. Growth of P. 
larvae after 3 days or 1 week is compared with the control of P. larvae (third column). 
 




2.3.4 Preparing cultures to further test inhibition 
Two inhibitory strains, A12 (a honey bee swab isolate from RT) and E8 (a honey 
bee swab isolate from 30˚C), were first selected to further test inhibition as they showed 
really good inhibition in the pairwise assays. They were cultured in 10 sterile 15 ml 
centrifuge tubes of 5 ml of NB and incubated at 30 ˚C. A12 was inoculated on NA in four 
12 well plates and incubated at RT for 4 weeks.  
After finding out E8 is a mixture of strains, some strains isolated from E8 namely 
E8.4 and E8.3A were inoculated each on NA in four 12 well plates at RT for 4w. 
2.3.4 Extraction of Metabolites  
The liquid cultures were centrifuged to pellet cells and extracted with EA 
followed by methanol. The solid cultures were extracted with EA and 1:1 methanol: 
chloroform. The agar was transferred to Erlenmeyer flasks and left to sit in ca. 100 ml EA 
for 24 h. The agar in the EA mixture was then filtered by gravity. The filtrate which is the 
EA extract was evaporated using vacuum while the solid cultures were re-extracted with 
1:1 chloroform: methanol (CM) solution and left to sit for 24 h before gravity filtration 
and vacuum rotary evaporation (figure 8). 
Extracts were evaporated and stored in the refrigerator at 4˚C, away from light, 
until further use to prevent contamination and degradation of extracts. Around 15 to 30 
mg of extracts were then dissolved in HPLC grade methanol for LC/DAD and LC/MS 
analysis. 




Figure 8. Scheme of method of extraction of solid cultures.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
2.3.5 Preliminary tests for activity (Well Diffusion Assay) 
Twenty µl of P. larvae in sterile deionized water at 0.5 OD was spread evenly 
over the surface of NA using a sterile cotton swab. Wells were made using sterile 1000 µl 
pipette tips and 20 µl of the crude extracts with approximate concentrations of 15- 30 
mg/ml were added to the wells to get preliminary activity results of the extracts. Distilled 
water and plain NA extracts were used as negative controls. The extracts were tested in 
duplicates or triplicates depending on the yield of the extracts. The diameters of the 
inhibition were recorded after 24h and used to compare activity. 
 
Figure 9. Graphical representation of well diffusion assay extracts against P. larvae (dark 
blue). Average radius of inhibition can be calculated from average diameter of area of 
inhibition (pale blue). Average radius = Average diameter/2 




2.3.6 Analysis of Extracts 
The methods were developed for general separation of secondary metabolites with 
the help of Patricia Granados at the Saint Mary’s University Centre for Environmental 
Analysis and Remediation (CEAR) Lab, Halifax, NS. 
Crude extracts were analyzed using an Agilent 1100 series LC-MS equipped with 
an iontrap mass spectrometer (Agilent 110 Series LC/MSD Trap) and a diode array 
detector. The 25 mg/ml samples of the extracts were filtered using a 0.22 µm syringe and 
run through a reverse phase chromatography with C-18 column (Zorbax Eclipse XDB C-
18, 4.6 x 75 mm, 3.5 microns), acetonitrile (ACN) with 0.1% formic acid as organic 
phase and milliQ water with 0.1% formic acid as aqueous phase. Two gradient methods 
were used during method development. The gradient method A involves elution of 
sample at a flow of 1ml/min through a gradient of 20% ACN for 25 mins, followed by 
80% ACN for 3 mins and 100% ACN for another 5 mins.  The gradient method B 
involved an isocratic flow of 20% ACN: milliQ water for 15 mins. The column was kept 
at a temperature of 30ºC and maximum pressure of 100 bar. UV chromatography was 
carried out at 212, 225, 254, 275 and 350 nm for each sample. Since the mass 
spectrometer was malfunctioning, only the LC-DAD was used to detect the presence of 
compounds in the samples that were then analysed with another mass spectrometer. 
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Method development of UHPLC/ESI-qTOF MS for active extracts analysis 
An Agilent Technologies 1290 Infinity II series mass spectrometer equipped with a 
quadrupole time of flight (qTOF) and coupled with an UHPLC was used to further 
analyse some extracts.  
Samples were run through a reverse phase C-18 column (Poroshell 120 EC-C18, 
3.0 x 150 mm, 2.5 micron) with acetonitrile with 0.1% formic acid as organic mobile 
phase and milliQ water with 0.1% formic acid as aqueous mobile phase at a flow of 0.6 
ml/min. The samples were run through the column using both gradient method A and B. 
The column was maintained at a temperature of 30ºC and maximum pressure of 600 bar. 
Samples were analyzed from 100 m/z to 2200 m/z using + Electrospray Ionization 
quadrupole time-of-flight mass spectrometry with a drying gas flow of 11 L/min at 350 
ºC.  
2.4 Fractionation of extracts 
The crude extract of each of the pure isolate strains (1 ml of 25 mg/ml in 
methanol) was fractionated using a gravity microcolumn with C18 silica (6.5 cm height, 
approximately 1 g) and an acetonitrile/water gradient (10 ml each of 0%, 10%, 20%, 
60%, 80%, and 100% acetonitrile in water). Each fraction was collected in scintillation 
vials and stored in the refrigerator at 4°C away from light for subsequent bioactivity 
testing and analysis. The fractions were tested using the well diffusion assay and 
analyzed as explained in section 2.3.3 and 2.3.4 respectively. 
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2.5 Identification of inhibitors 
Fifteen randomly selected inhibitory strains were revived and incubated for at 
least 24 h for PCR preparation. DNA was extracted by mixing 750 µl of 70% ethanol, 
glass beads and an inoculation loopful of the sample. The mixture was then vortexed 6 
times at high speed for 10 seconds each time.  
For sample preparation, 2 µl of 10 µM 16S rRNA FOR primer (AGA GTT TGA 
TCC TGG CTC AG ) and 10 µM 16S rRNA REV primer ( ACG GCT ACC TTG TTA 
CGA CTT) for bacterial samples, 2µl of 10 µM ITS 1F and 2 µl of 10 µM ITS 4 primers 
for fungal samples, 19 µl nuclease free water, 25 µl master mix (GoTaq® DNA 
Polymerase which is supplied in 2X Green GoTaq® Reaction Buffer (pH 8.5),  400 µM 
dATP, 400 µM dGTP, 400 µM dCTP, 400 µM dTTP and 3mM MgCl2) were used along 
with 2 µl of extracted DNA.34 PCR products were examined by using agarose gel 
electrophoresis and visualized using ethidium bromide and UV light. The DNA samples 
were sent to McGill University and Génome Québec Innovation Centre for Sanger 
Sequencing. 
Results 
3.1 Strain isolation  
From the honey bee samples, about 359 isolates were obtained using NA, NAA 
and NAC.  235 isolates comprising 99 from the exterior, 69 from beehive swabs 
incubated at 30 ˚C and 69 from beehive swabs incubated at RT were found using NA. 86 
isolates comprising of 69 from the exterior and 17 from beehive swabs at 30 ˚C were 
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isolated using NAC and 38 isolates comprising of 25 from the exterior and 13 from 





Table 1. Summary of number of isolates found using different media and conditions. 
Isolation of beehive swabs at RT was not completed with use of NAA and NAC. 
Media Honeybee exterior Beehive Swabs, 30 ˚C Beehive swabs, RT 
NA 99 69 69 
NAA 25 13 - 
NAC 69 17 - 
 
From wild bees, about 140 isolates have been found so far using NA. (The 
selective media such as NAA and NAC were not used due to time and workload 
limitations) 24 strains were isolated from guts of bumble bees under anaerobic 
conditions.  
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3.2 Potential inhibitors 
3.2.1 General antimicrobial screening 
 About 102 out of 359 isolates from honey bee samples showed inhibition against 
P. larvae. The pairwise assay using 12 well plates gave only qualitative insights on the 
inhibitory activity of the isolates. Moreover, these observations cannot show us if 
inhibition is caused by production of antagonistic compounds that harm P. larvae or 
competition for nutrients. Therefore, some isolates (A12 and E8) showing good inhibition 
were chosen to further test inhibition and find antimicrobial compounds. 
From the 24 strains isolated from bumble bee guts, 3 strains showed strong 
inhibition. Those strains did not grow on NA under aerobic conditions, indicating that the 
strains may be obligate anaerobe. Further tests needed to be done to confirm this 
observation. Frozen stocks of the isolates were revived for further testing. Upon revival 
the second time, less colony growth was seen and the appearance of the colonies also 
changed, which indicated that the viability of the cells decreased. Also, due to the slow 
growth of both test strains and P. larvae on NA under anaerobic conditions, it was 
difficult to observe cases of moderate inhibition. The modified pairwise assay may be 
more suitable to test inhibition of the test strains.  
From the modified pairwise assay performed on wild bee exterior isolates, 
inhibition could not be tested due to a reduction in the cell viability of P. larvae. The loss 
in cell viability was observed from unusual patterns and slowness of growth in P. larvae 
upon re-streaks or revival from frozen stocks. 
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3.2.2 Identification of selected inhibitors  
Of the previously selected candidates, A12 was identified as Bacillus Cereus 
(percent identity ≥ 99%) and E8 could not be identified due to high noise level in the 
sequence reported by Sanger Sequencing. The high noise level was indicative of the 
presence of more than one strain in E8. E8 was re-streaked to isolate the different strains. 
Subsequently E8 was found to contain at least 6 strains; 1 from Bacillus subtilis group 
(E8.1A), 2 belonging to Pseudomonas chloroaphis group (E8.1B, E8.3A), 1 as 
Debaromyces prosopidis (E8.2A) and a mixture of strains (E8.4). E8.4 contains at least 2 
unknown strains as the sample showed bands for both 16S and ITS primers in gel 
electrophoresis. The high noise level observed during its sequencing confirms the 
presence of more than one strain in E8.4. 
Out of the 15 selected inhibitors sent for Sanger sequencing, 9 were successfully 
identified (percent identity ≥99%) while the other 6 had a high noise to signal ratio and 
could not be sequenced. The 9 strains comprised of 1 related to Raoultella terrigena, 4 in 
Pseudomonas chloroaphis group, 2 to Debaromyces prosopodis, 1 Paenibacillus as 
Paenibacillus lactis and 1 belonging to the Bacillus subtilis group. 
3.3 Assessment of bioactivity and analysis of extracts 
3.3.1 Bioactivity of first batch of extracts 
From the first trial of well diffusion assay of crude extracts of A12 and E8 against P. 
larvae, the CM extract of 4w old A12 at RT, methanol extracts of 4w old liquid cultures 
of A12 and E8 showed really good inhibition with the former showing the highest 
activity (table 1). However, on the second trial of testing the extracts, the control NAP 
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showed inhibition, which indicated that the extracts were contaminated. Since the 
extracts got contaminated, they were no more viable for further analysis.  
Table 2.  Average radius of inhibition of agar well diffusion assay of extracts of solid and 
liquid cultures of A12 and E8 at different temperatures for 4 weeks. a- solid culture at 










      
3.2 Activity of A12 (identified as B. cereus) 
The CM extract of the solid cultures of A12 showed strong inhibition against P. 




Control NAP, EAa 0 
Control NAP, CMa 0 
A12, CMa 3.9 
A12, EAa 1.5 
A12, methanolb 3.0 
A12, EAb 0 
E8 liq. Methanolb 4.1 
E8 liq. – EAb 1.9 
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again for further analysis. LC/DAD with an isocratic gradient was run on the CM crude 
extract. The UV chromatogram was compared to that of the CM crude extract of NA 
(figure 11). Several peaks from A12 was detected indicating that fractionating the extract 
will be needed to find the anti- P. larvae antagonistic compounds. The crude extract was 
fractionated and analysed using UHPLC/qTOF-MS. Preliminary results are included in 
Appendix C 
Unfortunately, the activity of the extracts and fractions from the second extraction could 
not be tested against P. larvae due to loss of cell viability. 
  
Figure 10. Well diffusion assay of first batch of extracts; CM extract of 4w old A12. The 
assay is divided into 2 parts. One part is the well diffusion assay which is divided into 3 
fractions comprising of water as a control and 2 replicates of the test extracts. The other 
part is another test method, that involve dropping the test extract directly over the plate 
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streaked with P. larvae. It is comprised of a water control and one replicate of test 
extract. Inhibition is more visible through the well diffusion assay. 
 
   : Present in control 
Figure 11. UV chromatograms of CM extract of A12 4w old ran under isocratic gradient 





















































































































































































































































































































































































3.3.3 Activity of E8 (mixture of strains) 
The extracts of E8 showed strong to moderate inhibition against P. larvae (figure 12). 
However, it was discovered that E8 is a mixture of strains.  
Figure 12. Well diffusion assay of first batch of extracts; EA extract of 4w old E8 against 
P. larvae. The assay is divided into 2 parts. One part is the well diffusion assay which is 
divided into 3 fractions comprising of water as a control and 2 replicates of the test 
extracts. The other part is another test method, that involve dropping the test extract 
directly over the plate streaked with P. larvae. It is comprised of a water control and one 
replicate of test extract. Inhibition is more visible through the well diffusion assay. 
 
Since, E8 showed promising activity, isolates from E8 (E8.4 and E8.3A) were 
selected for further analysis. 4w old E8.4 and E8.3A solid cultures were extracted for 
further analysis. LC/DAD with an isocratic gradient was run on the crude extracts. The 
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labelled peaks in the chromatograms below show peaks that were either not found in the  
or were present at lower absorbance units  at their respective retention times in the 
controls. 
 Therefore, the labelled peaks may be indicative of the metabolites produced by 
the microbes. From the UV chromatograms, the retention time of the CM extracts of both 
E8.3A and E8.4 are very short (less than 4 mins) and the peaks are not well separated. 
However, the isocratic gradient seems to be working better with the EA extracts of E8.4 
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LC/DAD of E8.3A (identified as Pseudomonas chloroaphis) 
        : Absent in control    
Figure 13. UV chromatograms of EA extract of E8.3A ran under isocratic gradient of 
20% acetonitrile: water for 15 mins at ʎ= 254, 225, 350, 212, 275 nm.  
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Figure 14. UV chromatograms of CM extract of E8.3A ran under isocratic gradient of 
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LC/DAD of E8.4 (mixture of unknown strains) 
Figure 15. UV chromatograms of EA extract of E8.4 ran under isocratic gradient of 20% 
acetonitrile: water for 15 mins at λ= 254, 225, 350, 212, 275 nm. 
 
Figure 16. UV chromatograms of CM extract of E8.4 ran under isocratic gradient of 20% 
acetonitrile: water for 15 mins at λ= 254, 225, 350, 212, 275 nm.  
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3.4 Well diffusion assay of the second batch of extracts of A12, E8.3A & E8.4 
No growth of P. larvae was observed on the plate after 3 days and very little 
growth was seen after 1 week. P. larvae did not grow homogeneously and grew 
unusually slow in a different pattern. 




Figure 17. Post 2 weeks observations of well diffusion assay of second batch extracts 
against newly ordered P. larvae. Methanol and water were used as negative controls. This 
trial of well diffusion assay was unsuccessful as P. larvae did not grow homogeneously 
to allow for assessment of the extracts. 
 
4. Discussion 
4.1 Strain isolation 
Interestingly, isolates were obtained mostly from the exterior of bees relative to 
swabs of the beehives. The exterior isolates were slow growers, specially at the 
beginning. They were left to incubate for longer than the swabs which may have allowed 
for more microorganisms to grow.  
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4.2 Finding inhibitors 
Twelve well plates pairwise assay was suitable for screening a large amount of 
strains in a time efficient manner, as the activity of 3 test strains can be assessed per 
plate. However, it was challenging to determine the activity of test strains in some cases 
as the growth of test strains and P. larvae in the pairwise test would not differ much from 
their respective controls. 
Another general antimicrobial screening assay, perpendicular streak method was 
used in previous studies whereby a 20 mm streak of the test strain is made with a sterile 
cotton swab across the plate and incubated for a few days to allow the production of 
antagonistic substances. Then 3 to 5 streaks of P. larvae are made perpendicular to the 
test strain’s streak and left to incubate for a few days to assess inhibition.45 This method 
would give more insights on whether the metabolites of the test strains are causing 
inhibition as it allows test strains to produce potential antagonistic substances before 
inoculating P. larvae. If the metabolites of the test strains cause inhibition, restricted 
growth of P. larvae will be observed in the pairwise test.  The modified 12 well plates 
pairwise assay provides the same advantage as the perpendicular streak method and on 
top of that, it allows assess activity of more than one test strain at the same time. 
Inhibitors from wild bees could not be found yet because inhibition could not be 
assessed using the modified 12 well plate pairwise assay as the P. larvae was growing in 
neither the control nor the pairwise test. We confirmed that it is not due to contact 
independent inhibition i.e. inhibition caused by gaseous antagonistic compounds, because 
the P. larvae was not even growing well on a separate control. Comparison of the growth 
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pattern of our P. larvae (figure 19) with literature (figure 18), confirms that our P. larvae 
is behaving strangely which may due to loss in cell viability. 
 
Figure 18.  Physical appearance of colonies of P. larvae genotype ERIC I (a) and ERIC 
II (b) and (c). The P. larvae was isolated from AFB outbreaks in Italy 66 (Permission for 






Figure 19. P. larvae re-streak from newly revived ATCC 9545 P. larvae strain (ERIC I) 
with biofilm production. No biofilm is visible in any of the reported ERIC I and ERIC II 
genotypes of P. larvae isolated from AFB outbreaks in Italy (fig.18) 
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The reason for loss of viability of P. larvae and the unusual growth pattern such 
as formation of biofilms is unknown. Normally, cells change their genetic expression, 
resulting in changes in appearance or formation biofilms when they are highly stressed. 
A bacterial community can induce death in a part of the population in response to 
various stress conditions to favour the survival of the colony, including: oxidative stress, 
radiation exposure, nutrient deprivation, phage infections, and many others. 
Biofilms protect bacteria from stressing conditions as well as from other 
microorganisms that live in the same environment. Spore-forming bacteria produce both 
biofilm and endospores being able to respond more swiftly to environmental stresses. 
Moreover, biofilm is an optimal environment for sporulation.67 Since P. larvae is spore 
forming bacteria, the formation of biofilm of the bacteria can indicate that the bacteria 
were transformed due to exposure to stress conditions. 
4.2.1 Identification of inhibitors 
Some samples showed a high level of noise, which is indicative of the presence of 
nucleotides from different sources in the sample. It is very likely to occur due to the 
presence of more than one microbial strain in the isolates sequenced. Moreover, during 
Sanger Sequencing of a sample batch, an unexplained error of the presence of Indel 
homopolymer microsatellite contaminated short fragment, was reported in all the samples 
which affected the quality of the sequences. Since it was found in all the samples, it is 
highly possible that the Go Taq green master mix has degraded or was contaminated. 
Nonetheless, the presence of the Indel homopolymer microsatellite contaminated short 
fragment still enabled acquisition of good quality short sequences for BLAST analysis. 
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For the strains with approved quality of sequences, the ones with the highest 
number of hits and highest percent identity were chosen. All 9 identified strains can be 
found in the environment, such as in soil. These findings match with the isolates’ samples 
of origin which are beehive swabs of honey bees. 
 In most cases, all the top hits were found to belong to the same group of species. 
A group of bacterial species comprises of genetically closely related individuals. In some 
cases, such as identification of A12, it was difficult to distinguish between species due to 
some scores being the same, showing that the species were closely related to each other.  
For further identification, species specific primers can be used. In some cases, 
biochemical tests also can be used to distinguish among candidate species. For instance, 
E8.2A was identified by BLAST as Debaromyces prosopidis  and  Debaryomyces 
subglobosus with Debaromyces hasenii  as the second closest hit.  Debaryomyces 
prosopidis can be differentiated phenotypically from both varieties of Debaromyces 
hasenii, D. hansenii var. hansenii and D. hansenii var. fabryi by lack of growth on 
cellobiose after 2 weeks incubation and from the variety hansenii by a higher maximum 
temperature for growth.68  
The top hit for A12 was Bacillus Cereus and the other close hits belonged to the 
Bacillus Cereus group. The Bacillus cereus group contains closely related gram-positive 
bacteria such as B. anthracis but exhibit highly divergent properties. They are genetically 
very similar, but scientists have not classified them as one species as their metabolomics 
and behavior are significantly different. There is a wide difference in behaviours of B. 
Cereus strains themselves. Some strains of B. cereus can cause food-borne disease, while 
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some are also plant growth promoter and animal probiotics. 69 B. cereus strains can 
produce beta-lactamases and bacteriocins such as emetic toxins.70 On the other hand, B. 
cereus isolated from apiarian sources have been found in many studies to inhibit P. 
larvae by producing bacteriocin‐like inhibitory substances that has the potential to be 
combined with an Integrated Pest Management approach.62  
The fact that closely related B. cereus species can have different metabolomics 
suggests that it is highly possible that A12 is producing antimicrobial compounds that are 
yet to be discovered.  
16S rRNA is limited in its ability to differentiate the B. cereus group bacteria. The 
nucleotide sequences of the 16S rRNAs of the B. cereus group exhibited very high levels 
of sequence similarity (>99%) Likewise, Ash and Collins reported that even the 23S 
rRNA gene sequences of B. anthracis and an emesis-causing B. cereus strain were almost 
identical. However, a study was able to examine the phylogenetic relationships of B. 
cereus group strains using nucleotide sequences of groEL and sodA genes. 
The groEL genes, encode highly conserved housekeeping proteins that assist in proper 
protein folding (chaperons).71 
E8.4 contains at least one bacterial and fungal strain as genetic material was 
isolated when 16S and ITS primers were used respectively. E8.3A belongs to the 
Pseudomonas chloroaphis group and, more specifically, as Pseudomonas chloroaphis 
subsp aurantica. Pseudomonas chloroaphis has been found to be a biocontrol agent 
against plant pathogens caused by Fusarium graminearum. Pseudomonas chloroaphis 
produces phenanzines and oxysporumphenazine-1-carboxamide, an antifungal metabolite 
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that is required for biocontrol of plant diseases such as tomato foot and root rot.72 It will 
be interesting to find anti-P. larvae compounds as well from this strain.  
4.3 Separation and MS analysis of extracts 
The isocratic gradient provided better separation with both CM and EA extracts of 
A12. However, the E8.3A and E8.4 CM extracts were not well separated and had short 
retention times. This shows different gradient methods may be needed for extracts of 
different isolates. If retention times stay short after adjusting gradient, normal phase 
chromatography may be used for further analysis. 
The CM extract of A12 was fractionated, run through the isocratic gradient (Gradient 
method B) in UHPLC and analysed with qTOF-MS. Although the isocratic method was 
efficient using HPLC, the gradient does not seem efficient in separating the compounds 
using UHPLC, given short retention times (less than 4 mins) were observed. Gradient 
method A showed better separation in the crude extracts of A12 compared to the isocratic 
gradient. Therefore, gradient method A can be used as an attempt to better separate the 
fractions of A12. Preliminary results of mass spectra of the crude extracts and fractions of 
the CM extract of A12 are attached in Appendix C. 
Conclusion 
Novel microbial species such as Pseudomonas chloroaphis, Debaromyces 
prosopidis and Paenibacillus lactis isolated from beehive swabs have been found to 
inhibit P. larvae. Along with the mentioned novel species, B. cereus and B. subtilis that 
were heavily reported to show good inhibition against P. larvae were also isolated as A12 
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and E8.1A from our samples. CM extracts of A12 and E8 showed strong inhibition while 
EA extracts of E8 showed moderate inhibition against P. larvae. Since E8 showed 
stronger inhibition than A12, it will be interesting to see whether the inhibitory activity is 
due to a synergistic activity of the different strains together against P. larvae or the 
strains independently inhibit P. larvae. Reproducibility of the activity of extracts can be 
influenced by factors such as presence of contaminants, concentration of extracts and 
stability of compounds in the extracts. 
Future work 
Future work involves ensuring P. larvae recovery and quality from the newly 
ordered batch to allow further testing of extracts. The minimum inhibitory concentrations 
of the active fractions need to be determined to lower risks of toxicity. The CM fractions 
of A12 can be analysed to detect novel antimicrobial compounds produced by B. cereus 
as high inhibition was already observed from the first batch of extracts. Gradient method 
A will be performed for UHPLC/qTOF-MS on the fractions of A12 to elucidate 
compounds that inhibit P. larvae. 
It will be interesting to compare activity of E8 isolates with E8 to determine if 
inhibition is gone or reduced when the strains in E8 are separated. If A12 and E8.1 A 
produce novel inhibitory compounds that have not been reported in literature yet, more 
specific primers will be needed to characterize the Bacillus cereus and Bacillus subtilis 
species respectively.  
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 Moreover, there should be a focus on finding new compounds from the novel 
bacteria that were found to inhibit P. larvae. This can be helpful to avoid isolating 
already discovered antimicrobial compounds. Biochemical tests to distinguish between 
Debaryomyces prosopidis and Debaromyces hasenii can be pursued given their 
simplicity. 
The bumblebee microbial re-streaks for isolation need to be completed. The isolates 
should be tested against P. larvae using the modified 12 well plates pairwise assay to find 
inhibitors for discovery of anti-P. larvae compounds. Also, we could see if the inhibitors 
found can be used as probiotics for honey bees against P. larvae given the promise of 
probiotics in strengthening honey bee’s immunity. 
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Table 3. Identification of P. larvae inhibitor samples from honey bee isolates 
Sample ID, 
SS* ID of inhibitors 






A12, 61.36 Bacillus Cereus 
Bacillus 
Paramcycoides 100, 1 100 
 
Bacillus cereus  100, 6 100 




Bacillus albus 100, 1 100 
 
Bacillus luti 100, 1 100 
 
Bacillus 
nitratireducens 100, 1 100 
 
Bacillus tropicus 100, 1 100 
 
Bacillus anthracis 100, 1 100 











aurantica 100,2 99.87 
  
Pseudomonas 
chloroaphis 100,4 99.87 
  
Pseudomonas sesami 100,1 99.87 
  
Pseudomonas 
baetica 100,1 99.87 
  
Pseudomonas 
jessenji 100,1 99.87 










aurantica 100,2 99.87 
  
Pseudomonas sesami 100,1 99.87 
  
Pseudomonas 
baetica 100,1 99.87 
  
Pseudomonas 
jessenji 100,1 99.87 
E8.2A,63.8 Debaromyces 
Debaromyces 
prosopidis 99,1 100 
  
Debaryomyces 
subglobosus 99,1 100 
  





aurantica 100,2 99.87 
  
Pseudomonas 
chloroaphis 100,4 99.87 
  
Pseudomonas sesami 100,1 99.87 





baetica 100,1 99.87 
  
Pseudomonas 
jessenji 100,1 99.87 
  
Pseudomonas 
umsongensis 100,1 99.87 
E8.1A Bacillus subtilis Bacillus velezensis 100,2 99.58 
  
Bacillus subtilis 100,3 99.58 
  
Bacillus mojavensis 100,4 99.58 
  
Bacillus vallismortis 100,2 99.58 
  
Bacillus tequilensis 100,1 99.58 
  
Bacillus halotolerans 100,4 99.58 
w21, 63.70 Debaromyces 
Debaromyces 
prosopidis 100,1 100 
  
Debaromyces hasenii 100,1 99.83 
w20, 51.36 Paenibacillus  Paenibacillus lactis 100,1 99.39 








Sequences of identified inhibitors along with their chromatograms 














Figure 20. Chromatogram of Sanger sequencing of A12. 














Figure 21. Chromatogram of Sanger sequencing of E8.1B. 












Figure 22. Chromatogram of Sanger sequencing of E8.1A. 













Figure 23. Chromatogram of Sanger sequencing of E8.2A. 















Figure 24. Chromatogram of Sanger sequencing of E8.3A. 















Figure 25. Chromatogram of Sanger sequencing of w20. 
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Figure 26. Chromatogram of Sanger sequencing of w21. 
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Figure 27. Chromatogram of Sanger sequencing of w5. 
 

























Figure 29. UV chromatograms of CM extract of control NA ran under isocratic gradient 
of 20% acetonitrile: water for 15 mins at ʎ= 254, 225, 350, 212, 275 nm.  
 
Figure 30. UV chromatograms of EA extract of control NA ran under isocratic gradient 
of 20% acetonitrile: water for 15 mins at ʎ= 254, 225, 350, 212, 275 nm.  




























































































































































































































 DAD1 C, Sig=350,16 Ref =of f  (13FEB20\003-0301.D)


































































































Figure 31.  UV chromatograms of CM extract of A12 of 4w old ran under gradient 




























































































































































































































Figure 32. Total Ion Chromatograms of A12 crude extracts using gradient method B- 
20% acetonitrile isocratic gradient for 15 mins. 
 
 




Figure 33. Total Ion Chromatograms of fractions of A12 using gradient method B- 20% 
acetonitrile isocratic gradient for 15 mins. 
 
Figure 34. Total Ion Chromatogram of A12 crude extracts with method gradient A. v1 is 
the EA crude extract, v2 is the CM crude extract and methanol which is the solvent of the 
extracts.  
